Air India delivers first airport-to-door international pharma shipment | News
Air India has successfully executed its first "airport-to-door" international pharma shipment, marking a significant step in bolstering its cold chain logistics capabilities and expanding its service offerings for the pharmaceutical industry. The shipment originated in Hyderabad, India, and was delivered to a recipient in Sydney, Australia, showcasing the airline’s commitment to providing seamless and temperature-controlled transportation for sensitive cargo. This end-to-end service included customs clearance, ground handling, and specialized packaging to maintain the integrity of the pharmaceuticals throughout the journey.
The move signifies Air India’s ambition to become a key player in the rapidly growing pharma logistics market, which demands stringent temperature control and traceability. By offering a complete solution, from airport to final destination, Air India aims to attract pharmaceutical companies seeking reliable and efficient transportation for their valuable products. This initiative leverages strategic partnerships and investments in infrastructure to ensure the safe and timely delivery of critical medicines and healthcare products. The successful completion of this first shipment paves the way for Air India to expand its "airport-to-door" pharma service to other international destinations, further strengthening its position in the global air cargo market. The company aims to capitalize on the increasing demand for specialized pharma logistics solutions, driven by the growth of the pharmaceutical industry and the need for secure and temperature-controlled transport of vaccines, biologics, and other sensitive medical products.
Key Points
Read the Complete Article.
Boutique Travel VC raises investment cap from $1.5M to $10M to lead rounds and support portfolio companies through growth Travel...
Read moreDetails
